FAKTOR OPTIONSSCHEIN - AMGEN | Real-time BOERSE MUENCHEN 09:45:43 2024-05-13 EDT | ||
| 6.85 EUR | +1.18% |
|
| Current month | -38.90% | ||
| 1 month | -44.10% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-13 | 6.85 | +1.18% | 0 |
| 24-05-10 | 6.77 | +2.27% | 0 |
| 24-05-09 | 6.62 | -7.80% | 0 |
| 24-05-08 | 7.18 | -5.65% | 0 |
| 24-05-07 | 7.61 | -0.13% | 0 |
Real-time BOERSE MUENCHEN
Last update May 13, 2024 at 09:45 am
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HD2VEF |
| ISIN | DE000HD2VEF0 |
| Date issued | 2024-02-21 |
| Strike | 413.6 $ |
| Maturity | Unlimited |
| Parity | 14.48 : 1 |
| Emission price | 10.24 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 12.86 € |
|---|---|
| Lowest since issue | 6.13 € |
| Spread | 0.01 € |
| Spread % | 0.15% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
310.2
USD
Average target price
314.6
USD
Spread / Average Target
+1.45%
- Stock Market
- Certificates
- Certificat